Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Cardiothoracic surgery linked to limited diversity, uneven salaries | Improved TAVR outcomes in patients with concomitant MS

News You Need to Know Today
Cardiothoracic surgery linked to limited diversity, uneven salaries | Improved TAVR outcomes in patients with concomitant MS
Wednesday, December 11, 2024
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiothoracic surgery linked to a lack of diversity, uneven salaries: What can be done?

A brand new analysis explored diversity, equity and inclusion within the specialty of cardiovascular surgery. It also included several recommendations for leaders looking to help create change and improve patient care.

READ MORE >
Jobs hiring talent people human resources
Share on Twitter Share on Facebook Share on Linkedin

Cardiothoracic surgery linked to a lack of diversity, uneven salaries: What can be done?

Share on Twitter Share on Facebook Share on Linkedin
Jobs hiring talent people human resources
A brand new analysis explored diversity, equity and inclusion within the specialty of cardiovascular surgery. It also included several recommendations for leaders looking to help create change and improve patient care.
READ MORE >

Years of progress have made TAVR more effective when treating concomitant mitral stenosis

Newer balloon-expandable TAVR valves are associated with much better outcomes for patients presenting with both severe AS and severe MS than older models.

READ MORE >
Sapien 3 Ultra Resilia TAVR valves
Share on Twitter Share on Facebook Share on Linkedin

Years of progress have made TAVR more effective when treating concomitant mitral stenosis

Share on Twitter Share on Facebook Share on Linkedin
Sapien 3 Ultra Resilia TAVR valves
Newer balloon-expandable TAVR valves are associated with much better outcomes for patients presenting with both severe AS and severe MS than older models.
READ MORE >

Featured Articles

First surgical device of its kind granted key FDA exemption

This update helps ensure Artivion's AMDS Hybrid Prosthesis can be used to treat high-risk patients as the FDA makes its final approval decision. The news came as Artivion works to bounce back from a cybersecurity attack that occurred in November.

READ MORE >
Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.
Share on Twitter Share on Facebook Share on Linkedin

First surgical device of its kind granted key FDA exemption

Share on Twitter Share on Facebook Share on Linkedin
Artivion, an Atlanta-based medical device company, has received a Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for its AMDS Hybrid Prosthesis designed to treat DeBakey Type 1 dissections when malperfusion occurs. This HDE ensures select patients can be treated with the device before the FDA makes its final approval decision.
This update helps ensure Artivion's AMDS Hybrid Prosthesis can be used to treat high-risk patients as the FDA makes its final approval decision. The news came as Artivion works to bounce back from a cybersecurity attack that occurred in November.
READ MORE >

TAVR/PCI bests SAVR/CABG when treating severe AS and complex CAD

Percutaneous treatment was linked to improved survival and fewer adverse events than surgery when patients presented with both symptomatic severe aortic stenosis and complex coronary artery disease. 

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

TAVR/PCI bests SAVR/CABG when treating severe AS and complex CAD

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Percutaneous treatment was linked to improved survival and fewer adverse events than surgery when patients presented with both symptomatic severe aortic stenosis and complex coronary artery disease. 
READ MORE >

TAVR survival less likely when patients are depressed

Screening TAVR patients for signs of depression prior to treatment could help providers adapt as necessary and deliver better patient care.

READ MORE >
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
Share on Twitter Share on Facebook Share on Linkedin

TAVR survival less likely when patients are depressed

Share on Twitter Share on Facebook Share on Linkedin
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.
Screening TAVR patients for signs of depression prior to treatment could help providers adapt as necessary and deliver better patient care.
READ MORE >

In Case You Missed It

FDA approves new short-term treatment for AFib, atrial flutter in critical care settings

Landiolol, sold by AOP Health under the brand name Rapiblyk, is an intravenous treatment designed to start working right away.

READ MORE >
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new short-term treatment for AFib, atrial flutter in critical care settings

Share on Twitter Share on Facebook Share on Linkedin
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Landiolol, sold by AOP Health under the brand name Rapiblyk, is an intravenous treatment designed to start working right away.
READ MORE >

Prosthesis-patient mismatch after TAVR: 5 key findings related to patients with small annuli

PPM is still relatively common after TAVR, especially among patients with a small aortic annulus. What can be done to minimize the risk of PPM? Does valve type play a role? Researchers explored those questions, and many others.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

Prosthesis-patient mismatch after TAVR: 5 key findings related to patients with small annuli

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
PPM is still relatively common after TAVR, especially among patients with a small aortic annulus. What can be done to minimize the risk of PPM? Does valve type play a role? Researchers explored those questions, and many others.
READ MORE >

Mediterranean diet helps older adults live longer lives with fewer heart issues

The Mediterranean diet, named after the traditional eating habits of Greece and Italy, was once again linked to multiple cardiovascular benefits. The focus of this latest meta-analysis was adults over the age of 60.

READ MORE >
Mediterranean diet
Share on Twitter Share on Facebook Share on Linkedin

Mediterranean diet helps older adults live longer lives with fewer heart issues

Share on Twitter Share on Facebook Share on Linkedin
Mediterranean diet
The Mediterranean diet, named after the traditional eating habits of Greece and Italy, was once again linked to multiple cardiovascular benefits. The focus of this latest meta-analysis was adults over the age of 60.
READ MORE >

In Other News

Telehealth visits not to blame for uptick in imaging orders, study shows

Despite some assumptions that telehealth visits increase the unnecessary utilization of diagnostic services, new data suggest the opposite may be true. 

READ MORE >
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Share on Twitter Share on Facebook Share on Linkedin

Telehealth visits not to blame for uptick in imaging orders, study shows

Share on Twitter Share on Facebook Share on Linkedin
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Despite some assumptions that telehealth visits increase the unnecessary utilization of diagnostic services, new data suggest the opposite may be true. 
READ MORE >

Stanford HAI lookback: Best-read blog posts of 2024

The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.

READ MORE >
artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Stanford HAI lookback: Best-read blog posts of 2024

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI in healthcare
The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Key FDA approvals | Radiation during heart scans | Whole-body MRI provider offers AI-powered CCTA | 3D echo & CHD
Cardiologists & AI policies | FDA clears ‘world’s smallest camera’ | Prior authorization doing harm | Comparing DOACs
Faster coronary IVL catheter impresses | CCTA now an essential tool | Treating ‘no-option’ chest pain patients | RDN updates
Radiotracer shortage winding down | FDA clears new catheter | The high costs of healthcare | Vascular surgeons deliver value
TAVR Highlights: A new implantation technique | The world's first polymeric valve | Planning ahead | Oversizing boosts survival
Medtronic announces $550M acquisition | Faster IVL catheter impresses | Who do Americans trust? | Burnout among surgeons
Cardiologist develops new heart device | FDA approves pacing lead for LBBAP | A warning about universal screening

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …18
    • Page 19
    • Page 20
    • Page 21
    • Current page 22
    • Page 23
    • Page 24
    • Page 25
    • Page 26 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup